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Abstract 
Staphylococcus epidermidis is a common cause of biomedical device-associated infections. 
Agr is the major quorum sensing system in staphylococci and regulates virulence factors. 
Four agr-specificity groups exist in S. epidermidis, and chronic S. epidermidis infections are 
hypothesised to select for agr-negative phenotypes. Therefore, we investigated S. epidermidis 
strains from prosthetic joint- and catheter-associated infections to establish i) whether an 
infection selects for an agr-negative phenotype; ii) the importance of PSMγ and iii) if the 
agr-specificity group is infection dependent. S. epidermidis nasal isolates from healthy 
volunteers were used as controls. The distribution of agr-specificity groups was significantly 
different between infection and control episodes, but did not distinguish between the 
infection types. PSMγ secretion was used to determine agr-activity and HPLC analysis 
showed that 44% of prosthetic and 32% of catheter-associated episodes produced no PSMγ in 
comparison to 8% of the control strains. However, PSMγ expression did not always correlate 
with RNAIII up-regulation, indicating that PSMγ synthesis is likely influenced by additional 
post-transcriptional control. The data suggests chronic S. epidermidis infections favour agr-
specificity group 1 but the results suggest that they do not select for an agr-negative 
phenotype. Further studies are required to explore the mechanisms underlying the selection 
and survival of these S. epidermidis phenotypes isolated from biomedical device-associated 
infections.  
 
Introduction 
Infections are a major problem associated with biomedical devices, such as central venous 
catheters, prosthetic joints, cardiac pacemakers, heart valves and cerebrospinal fluid-shunts. 
A major concern in these infections is their chronic persistence and recalcitrance to 
antibiotics, making the removal of the infected device necessary. The commensal 
Staphylococcus epidermidis is a leading cause of nosocomial biomedical device-associated 
infections (1). S. epidermidis has evolved sophisticated regulatory systems and mechanisms 
allowing adaption to changing environmental conditions during colonization and, in 
particular during an infection. Critical to the pathogenesis of biomedical device-associated 
infections is the ability of the bacteria to adhere to the biomaterial surface and subsequently 
produce biofilm. Thereby, S. epidermidis successfully evades the host’s immune system and 
becomes intrinsically resistant against most first line antibiotics (2).  
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An important factor suggested to influence the pathogenesis of S. epidermidis is its ability to 
produce pro-inflammatory peptides named phenol soluble modulins (PSMs) (3). The PSM 
family in S. epidermidis consists of PSMα, PSMβ1, PSMβ2, PSMδ, PSMε and PSMγ/δ-toxin 
(4). PSMs have been associated with a strong pro-inflammatory effect, as they can induce 
cytokine release in monocytes, activate the HIV-1 LTR in macrophage-like cells, and induce 
NFκB production (3). They are also chemotactic for leukocyte subsets and cause 
degranulation and inhibit human neutrophil apoptosis (5). PSMs like many toxins and surface 
proteins involved in the colonisation and persistence of S. epidermidis infections are 
regulated by the quorum sensing accessory gene regulator (agr) system (6, 7). PSMs are also 
involved in biofilm maturation and detachment as well as bacterial defence against human 
neutrophils (8, 9).  
 
In staphylococci, the agr system is responsible for the regulation of various virulence factors 
(10). The agr system consists of four genes (agrA, agrB, agrC and agrD) that are divergently 
co-transcribed by RNAII (a density dependent autoinducing system), and RNA111 (an RNA 
effector molecule), which also includes an open reading frame encoding PSMγ (-toxin) 
(Supplemental Fig. 1) (10). AgrD contains the sequence of the autoinducing peptides (AIP) 
generated by proteolytic processing through AgrB. The AIP is bound by AgrC, which is a 
membrane-bound receptor of the two-component system AgrC/AgrA. At a threshold 
concentration, AgrC phosphorylates or dephosphorylates AgrA. Then, activated AgrA, in 
conjunction with SarA, activates the two agr promoters P2 and P3 leading to rapid 
autoinduction of the agr system and synthesis of the effector molecule RNAIII, which in turn 
controls the transcription of the hld gene leading to the expression of PSMγ. In S. aureus and 
S. epidermidis, agr is activated during transition from exponential growth to the stationary 
phase and attenuates expression of several cell surface proteins, whilst increasing the 
expression of many secreted virulence factors. Agr activity can be determined by the amount 
of PSMγ expressed, as the hld gene is encoded within RNAIII (6, 11). Previous studies have 
suggested that strains with agr-negative phenotypes are frequently associated with infections 
(10, 12), and the development of thicker biofilms (12). This is also supported by an S. 
epidermidis 1457Δagr-mutant which colonised a subcutaneous catheter with significantly 
higher cell numbers consistent with its higher biofilm-forming capacity, whilst the wild type 
had higher cell numbers in the surrounding tissues, indicating a higher degree of invasiveness 
(12). In addition, the exogenous addition of PSMγ decreased biofilm formation, thus it was 
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hypothesized that the toxin might interfere with biofilm accumulation mechanisms in the later 
stages of biofilm formation (12). There are four agr-specificity groups in S. epidermidis, that 
differ in the hypervariable region of agrBCD and influence the amino acid sequence of the 
AIP (Supplemental Fig. 1) (13). It has been shown that AIP peptides from different agr-
specificity groups are mutually inhibitory (12). A study by Carmody and Otto (14), 
demonstrated that agr-specificity groups may be associated with certain S. epidermidis 
infections. However the isolates used were not well characterised. Thus the aim of this 
present study was to elucidate the relationship between the ability of previously well 
characterised S. epidermidis isolates from different biomaterial-associated infections to 
produce PSMγ (15, 16); and if variations exist, confirm their relationship with an agr-
negative phenotype, specific agr-specificity group and/or specific biomaterial-associated 
infection.  
 
Materials and Methods 
Bacteria strains 
A total of 100 previously characterised prosthetic joint infection (PJI) isolates from 50 
patients, and 40 isolates from central venous catheter infections (16 patients) collected 
between 1998 and 2004 in the ENDO-Klinik and University Hospital Hamburg-Eppendorf 
were used (15, 16). In each PJI case, staphylococcal isolates were obtained under strict 
aseptic conditions from independent pure cultures of a preoperative hip or knee joint aspirate 
and an intraoperative tissue specimen. The mean time interval between joint aspiration and 
intraoperative tissue specimen recovery was 11 weeks (median = 9 weeks). The central 
venous catheter infection isolates were recovered from the blood cultures of 16 bone marrow 
transplantation patients (2-5 isolates per patient, recovered 2 to 72 days after bone marrow 
transplantation). These S. epidermidis strains were regarded as invasive strains, as at least two 
clonally identical or closely related isolates were obtained from cultures of blood drawn at 
different time points or from independent cultures of blood drawn at one time per patient 
(16). Twenty six isolates from the nasal swabs of healthy volunteers were used as controls. 
Isolates were streaked from frozen stocks onto Columbia agar supplemented with 5 % horse 
blood (Oxoid, Thermo Fisher Scientific, Loughborough, UK), and incubated overnight at 37 
°C, and were used in the subsequent experiments. 
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Identification of agr-specificity groups 
Genomic DNA was isolated from bacteria cultured overnight in PY broth (1% peptone, 0.5% 
yeast extract, and 0.5% NaCl; all from Thermo Fisher Scientific) using a QIAmp mini kit 
(Qiagen, Crawley, UK) following the manufactures instructions. The primers and PCR 
conditions are summarised in Supplemental Table 1. The agr hypervariable region was 
amplified using Taq polymerase (Invitrogen, Paisley, UK) with primers specific to agr-
specificity group 1 and agr-specificity group 2, 3 and 4 (Invitrogen), resulting in a product of 
approximately 500bp. Restriction fragment length polymorphism (RFLP) using restriction 
enzymes, Dra1 and Dre1 (Promega, Southampton, UK) was used to confirm the agr-
specificity groups, as Dde1 cuts all agr-specificity groups, whilst Dra1 cuts only agr-
specificity groups 2, 3 and 4. Nucleotide sequencing (Eurofins MWG Operon, London, UK) 
was used to differentiate between agr-specificity groups 2, 3 and 4.  
 
PSMγ -production analysis 
To analyse the production of PSMγ, bacteria were cultured in basic media (0.5% yeast 
extract, 0.5% NaCl, 0.1% K2HPO4, and 0.1% glucose; all from Thermo Fisher Scientific) for 
8h from a starting OD600 of 0.05, then centrifuged and the supernatant kept for High 
Performance Liquid Chromatography (HPLC) analysis. A Resource PHE 1-ml column (GE 
Healthcare, Little Chalfont, UK) and an Applied Biosystem Vision BioCAD HPLC 
instrument was used as described previously (11). S. epidermidis PSMγ elutes at a retention 
time of about 7.5 min (after sample injection) as a distinct peak. The identity of PSMγ was 
determined after peak fractionation using a MALDI-ToF/MS (Bruker Daltonik GmbH, 
Germany), should appear as a peak of approximately 2849Da (3).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
 
Transcription analysis of RNAIII  
Quantitative RT-PCR was used to analyse the transcription of RNAIII. RNA was extracted 
from 2 and 8h cultures of 22 pairs of prosthetic joint infection isolates, 22 catheter isolates (8 
patients) and 9 control nasal swab isolates, using a modified protocol described by Kenny et 
al. (17) and the Promega SV Total RNA isolation kit (Promega, Southampton, UK). Cells 
were harvested by centrifugation for 10min at ambient temperature, resuspended in 3ml 
sterile PBS (Sigma, Dorset, UK), then a 1.5ml portion of the cell suspension was mixed with 
3ml of RNA protect solution (Qiagen) and incubated for 5 min at ambient temperature. Cells 
were centrifuged for 10min at ambient temperature and the pellet frozen at -20°C until ready 
to analyse. The samples were thawed and resuspended in 180µl of TE buffer (10mM Tris; 
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1mM EDTA (pH 8.0); Thermo Fisher Scientific), centrifuged to remove any residual RNA 
protect solution, and resuspended in 180µl TE buffer containing 200 µg/ml lysostaphin 
(Sigma), 400 U/ml mutanolysin (Sigma) and 40 µg/ml proteinase K (Qiagen). Samples were 
incubated at 37°C for 1-2h, with occasional shaking, then 75µl of RNA lysis buffer and 
350µl of RNA dilution buffer from the SV RNA isolation kit were added to the suspension 
and mixed gently by inversion. The subsequent extraction of RNA was performed according 
to the instructions of the manufacturer. Extracted RNA was quantified with a NanoDrop 
ND100 spectrophotometer (Thermo Fisher Scientific, UK), and diluted to 10µg/ml. 4µg/ml 
of RNA was used for first-strand cDNA synthesis with the iScript cDNA synthesis kit (Bio-
Rad, Hemel Hempstead, UK) in a total volume of 20µl. 3µl of cDNA was used as a template 
in real-time PCR analysis with a SensiMix SYBR mix (Bioline, London, UK) and primers for 
RNAIII and gyrB in a RotorGene 6000 instrument (Qiagen) using the conditions outlined in 
Supplemental Table 1. All RT-PCR analyses were performed in triplicate for at least two 
independent experiments. Relative transcriptional levels within distinct experiments were 
determined using the 2-ΔΔCt method which compares RNAIII transcription at 2 and 8h (18) 
and gyrB as the reference housekeeping gene. A 3-fold difference in 2-ΔΔCt was used as a cut-
off point for RNAIII transcription up-regulation between 2 and 8h.  
 
Biofilm assay 
The biofilm phenotype of the S. epidermidis isolates was determined with a semi-quantitative 
adherence assay using 96-well tissue culture plates (Nunc, UK) to measure attachment and 
accumulation of biofilm on the plastic surface, as described previously (19). Biofilm-positive 
strains were defined as strong biofilm: mean OD570 greater than 0.7; biofilm positive: mean 
OD570 0.5-0.69; and weak biofilm positive: mean OD570 0.2 - 0.49. Biofilm negative strains 
had a mean OD570 less than 0.19. 
 
Statistical analysis 
Data were analysed using a Fisher exact test and ANOVA using SPSS software, with the 
level of significance set at p < 0.05. 
 
Results 
Identification of agr-specificity groups.  
The agr-specificity groups (Table 1) in the prosthetic joint infection (PJI; 50 pairs), catheter 
infection (16 patients) and control nasal swab (n = 26) isolates were established using 
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specific PCR primers and RFLP to differentiate between the 4 agr-specificity groups. The 
results showed that agr specificity group 1 was most common among the PJI and catheter 
episodes, with 74 and 90% prevalence respectively. Isolates with agr specificity group 2 and 
3 were also identified in 16 and 10% of PJI episodes respectively, whilst the remaining 
catheter isolates (10%) were all agr specificity group 2. Agr-specificity group 4 was only 
found in one PJI patient. In comparison, the control nasal swab isolates analysed were equally 
distributed in agr groups 1-3 and none in 4 (Table 1). The agr-specificity group of isolates 
from the same patients were identical in all cases. The distribution of agr-specificity groups 
was significantly different between infection episodes and control nasal swab isolates (p < 
0.05), whilst the agr-specificity group distribution between prosthetic and catheter episodes 
was not (p > 0.05).  
 
PSMγ production analysis 
PSMγ production was used to establish agr activity within the isolates using HPLC (Table 2 
and Supplemental Figure 2) and thus determine if isolates had an agr negative phenotype. In 
agr active isolates (Supplemental Figure 2), a peak was observed as expected after about 7.5 
min in HPLC separation (11), and analysis of this peak using MALDI-ToF/MS showed a 
distinct peak of 2840 Da (not shown), thus confirming the presence of PSMγ. Similar 
analysis of all isolates (Table 2) confirmed that 44% of the PJI ones and 32% of those from 
catheters produced no PSMγ in comparison to only 8% of control nasal swab isolates; and no 
PSMγ production was found in any agr-specificity groups irrespective of isolate source. The 
differences observed in PSMγ production between infection (PJI or Catheter) and control 
nasal swab isolates was significant (p < 0.05), but no significant difference was observed 
between the PJI and catheter isolates (p > 0.05). Interestingly, a difference in PSMγ 
production was observed between 26% of the PJI pairs and 19% of the catheter isolates from 
the same patient, that is one isolate produced PSMγ whilst the other did not; and such a 
phenotypic difference was observed consistently in replicate experiments.  
 
Transcription analysis of RNAIII  
RNAIII is only transcribed if the agr locus is active, therefore RNAIII up-regulation was 
analysed in 22 pairs of PJI isolates, 22 catheter isolates (8 patients), and 9 control nasal swab 
isolates), and a 3-fold difference between  in 2-ΔΔCt used as the cut-off point. The results 
showed that RNAIII was transcribed by 65 of the isolates tested (Supplemental Table 2), 
despite the fact that 24 of these isolates did not produce PSMγ according to the HPLC results. 
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No significant association was found between RNAIII transcription and PSMγ production for 
the PJI, catheter or control isolates (p > 0.05) (Figure 1). However, the 3-fold increase in the 
RNAIII transcribed by the catheter isolates was significantly greater than that observed in the 
PJI and control isolates (p < 0.05). Furthermore, median values for RNAIII transcription in 
PSMγ positive isolates were higher than in PSMγ negative isolates for both infection types 
but was not statistically significant (p > 0.05).  
 
Biofilm formation 
The ability of the PJI, catheter and nasal isolates to form biofilms was tested using a semi-
quantitative adherence assay (19). Biofilm-positive isolates were defined as strong, positive 
or weak biofilm formers and the results are shown in Table 3. The ability of the isolates to 
form a biofilm was also correlated to their agr type and whether they were PSMγ positive or 
negative. Of the PJI isolates 66% were biofilm positive and all the strong biofilm producers 
(13 isolates) belonged to agr specificity group 1, with isolates from agr specificity group 2, 3 
and 4 producing weaker biofilms. In comparison, 83% of the catheter isolates were biofilm-
positive, with 9 isolates forming strong biofilms, again all belonging to agr specificity group 
1. Only 1 of the nasal isolates produced a positive biofilm, whilst 9 isolates were weak 
biofilm producers and 16 were biofilm negative, from agr specificity groups 1, 2 and 3. No 
significant differences were seen between agr specificity group and ability to form a biofilm 
(p > 0.05).  
 
An agr-negative phenotype has been associated with stronger biofilms. However, of the 13 
PJI strong biofilm producers, only 4 were agr-negative, and of the 9 catheter-associated 
strong biofilm producers only 4 were agr-negative (Table 3). No significant difference was 
observed between PJI, catheter or nasal isolates and whether they had an PSMγ 
positive/negative phenotype (p = > 0.05).  
 
 
Discussion 
The agr quorum sensing system is responsible for the regulation of many factors involved 
with S. epidermidis colonisation, immune evasion and activation (5, 20). Four different agr-
specificity groups have been identified in S. epidermidis (13) and have been linked with 
specific clinical infection entities in S. aureus (21). This study investigated the relationship 
between the differential ability of S. epidermidis strains isolated from prosthetic joint 
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infections (PJI) and catheter infections to produce PSMs, and whether any variations 
identified were associated with a specific agr-specificity group, agr-negative phenotype 
and/or biomaterial-associated infection.    
 
Firstly, the distribution of agr-specificity groups in S. epidermidis isolates from a strain 
collection of 100 prosthetic joint infections (50 pairs) and 40 catheter infections (16 patients) 
showed agr-specificity group 1 as the most prominent type in both prosthetic joint infection 
and catheter isolates (74 and 90%), whereas there was no significant specificity group in the 
control nasal swab isolates from healthy volunteers (38, 31 and 31%). Three other studies 
looking at agr-specificity groups in S. epidermidis infections, also found agr-specificity 
group 1 common in infection isolates (4, 14, 22) with fewer agr-specificity group 2 and 3 
isolates. Two of these studies had similar values of agr-specificity group 1-3 within the 
commensal isolates, thus substantiating the results obtained in this current study. However, in 
the Li et al. (22) study, agr-specificity group 2 was significantly more dominant at 51%. A 
possible agr-specificity group 4 was found in a PJI episode in this current study and in a 
commensal isolate in the Hellmark et al. study (4). Agr-specificity groups in relation to other 
specific S. aureus infections have also been investigated, and have been found to correlate 
broadly with strain genotypes (23-25). Campoccia et al. [37] found differences in agr-
specificity group prevalence in orthopaedic implant infections which were dependent on 
whether the isolate was from a sporadic or epidemic infection. Hence, there is strong 
evidence to suggest that specific agr-specificity groups in S. epidermidis are also associated 
with particular clinical infections.  
 
Agr-negative phenotypes have been proposed to be common in infection isolates in 
comparison to commensal ones (10) and have been associated with increased biofilm 
formation, an important virulence factor in S. epidermidis implant associated infections (6, 
12). Thus a second hypothesis was that infection isolates may select for an agr-negative 
phenotype. Firstly, PSMγ production was analysed, as its production is assumed to signify an 
active agr system. The results showed significantly fewer of the infection isolates produced 
PSMγ in comparison to the control nasal swab ones (p < 0.05), suggesting that they have an 
agr-negative phenotype, thus correlating to previous studies (10). Specifically, these results 
correlate with Vuong et al. (12, 20), as they also found significantly more agr-negative 
phenotypes in their clinical isolates than in their healthy volunteer isolates. It has also been 
suggested that having an inactive agr system would be advantageous during prosthetic joint 
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and catheter infections as both are associated with biofilm formation, and PSMγ expression is 
known to affect biofilm formation (6). However, this current study found no significant 
difference between being agr-negative/positive and biofilm formation in any of the PJI, 
catheter or nasal isolates (p > 0.05). A possible reason for this is the fact that the agr system 
is not the only regulatory system that influences biofilm formation in S. epidermidis, as at 
least four unlinked regulatory gene loci have been identified to have a role in S. epidermidis 
biofilm formation (26, 27).  
 
The fact that PSMγ negative isolates were detected signifies that it is not critical to the 
survival of S. epidermidis in vivo, but would influence the ability of the bacteria to disperse as 
this is thought to be PSMγ dependent (6, 8). Surprisingly, differences within prosthetic joint 
infection pairs and catheter patient samples were observed. This observation was unexpected, 
as different infection episodes from the same patients had the same agr-specificity group and 
were clonal according to previous work (15, 16). Hence to substantiate the PSMγ results 
RNAIII transcription was analysed in a selection of the isolates. They showed that 64 out of 
72 isolates transcribed RNAIII, despite 24 of these not producing PSMγ. The amount of 
RNAIII transcribed in the PSMγ negative isolates was lower than in the PSMγ positive ones 
but not significantly, thus suggesting a possible delay in RNAIII transcription resulting in no 
PSMγ production or not enough being produced for detection using HPLC. It has previously 
been shown in S. epidermidis and S. aureus that there is a 1-2h delay between RNAIII 
transcription, hld translation and PSMγ expression, due to the fact that the hld gene is 
embedded in the gene encoding RNAIII (20). Another study has also suggested that in S. 
aureus, using PSMγ  production as an indicator of agr activity was not always accurate when 
dealing with clinical isolates (28). Hence in this present study it is possible that in some 
cases, PSMγ was produced but to a sub-optimum level for HPLC detection, thus suggesting 
that despite RNAIII being transcribed to comparable amounts, an unknown post-transcription 
or post-translational mechanism may influence PSMγ secretion. 
 
Another factor that has not been considered so far, is that in S. aureus it has been shown that 
AgrA rather than RNAIII influences PSMγ expression, and that the expression of the hld 
gene despite being embedded within RNAIII is under the strict regulation of the agr locus 
and not RNAIII expression (29). Such a relationship has yet to be elucidated in S. 
epidermidis, but would certainly explain the discrepancy observed in this study between 
PSMγ expression and RNAIII transcription. In S. aureus, mutation in the 3’end of agrA have 
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been shown to result in a further 2-3 hours delay, leading to the lack of PSMγ expression 
(28), whilst mutations in S. epidermidis agrC and agrA have previously been suggested to 
result in no agr expression (12). However, despite finding SNPs within the 3’end region of 
agrA and agrC in isolates within the current study (results not shown), there was no particular 
correlation between the presence of these SNPs and PSMγ expression.   
 
To conclude, the results presented in this study indicate that in S. epidermidis, specific agr-
specificity groups are associated with particular clinical infections. Assuming that no PSMγ 
production is indicative of an agr-negative system, it may be concluded that chronic 
infections such as prosthetic joint infections are frequently associated with agr-negative 
phenotype in comparison to nasal isolates from healthy volunteers. This would be 
advantageous to the persistence of the bacteria as it could produce thicker biofilms which aid 
in evasion of the host immune system. However, if RNAIII transcription is used to define the 
activity of the agr system, chronic infection isolates are not associated with an agr-negative 
phenotype. Thus the discrepancy observed between RNAIII transcription and PSMγ 
production warrants further study if we are to fully understand the role of the agr system in 
infections. 
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Figure and Table Legends 
 
Table 1. Distribution of agr-specificity groups among PJI, Catheter and Nasal swab isolates 
The number in brackets refers to the overall percentage of isolates from each source in each agr-specificity 
group. 
 
Table 2. Distribution of PSMγ-production among the infection types and nasal swab isolates 
Fisher’s Exact results: PJI vs. Control, p < 0.05; Catheter vs. Control, p < 0.05; PJI vs. Catheter, p = 0.042 
 
Table 3. Biofilm formation results with correlation to agr specificity group and agr 
positive/negative phenotype based on the PSMγ results. 
No significant differences between agr specificity group and ability to form a biofilm in PJI, catheter or nasal 
isolates, p > 0.05.  
Statistics of PJI ability to form a biofilm vs. PSMγ positive/negative, p = 0.284; Catheter ability to form a 
biofilm vs. PSMγ positive/negative, p = 0.599; Control ability to form a biofilm vs. PSMγ positive/negative, p = 
0.129 
 
Figure 1. Box-plot analysis correlating PSMγ production with RNAIII transcription between 
2 and 8h 
 
Supplemental Table 1. Primers used in this study, and the PCR/qRT-PCR conditions used 
 
Supplemental Table 2. Detailed analysis of the HPLC and qRT-PCR results  
No significant difference in RNAIII transcription or PSMγ between Prosthetic episodes / Catheter episodes & 
Control, p > 0.05 
 
Supplemental Figure 1. Schematic representation of the function of the agr system of 
Staphylococcus, including the amino acid peptides of S. epidermidis specificity groups 1-4 
 
Supplemental Figure 2. Spectral results from HPLC analysis of S. epidermidis 8h culture 
supernatants showing the production of PSMγ (peak) or no production (flat-line) 
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Figure 1. Box-plot analysis correlating PSMγ production with RNAIII transcription between 
2 and 8h 
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Supplemental Figure 1. Schematic representation of the function of the agr system of 
Staphylococcus, including the amino acid peptides of S. epidermidis specificity groups 1-4. 
 
 
 
Supplemental Figure 2. Spectral results from HPLC analysis of S. epidermidis 8h culture 
supernatants showing the production of PSMγ (peak) or no production (flat-line). 
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Table 1. Distribution of agr-specificity groups among PJI, Catheter and nasal swab isolates.  
 
 
 
 
 
 
The number in brackets refers to the overall percentage of isolates from each source in each agr-specificity 
group. 
 
 
 
 
Table 2. Distribution of PSMγ-production among the infection types and nasal swab isolates 
 
Fisher’s Exact results: PJI vs. Control, p < 0.05; Catheter vs. Control, p < 0.05; PJI vs. Catheter, p = 0.042 
 
 
  
 agr group 1 agr group 2 agr group 3 agr group 4 
PJI 37 (74%) 8 (16%) 4 (8%) 1 (2%) 
Catheter 15 (94%) 1 (6%) 0 0 
Control 10 (38%) 8 (31%) 8 (31%) 0 
  PJI Catheter Control 
  
Distribution per 
isolate (n = 100) 
Variation 
between 
episodes 
(n = 50) 
Distribution per 
isolate (n = 40) 
Variation 
between 
episodes 
(n = 16) 
Distribution per 
isolate (n = 26) 
  
PSMγ  
positive 
PSMγ  
negative 
PSMγ  
positive 
PSMγ  
negative 
PSMγ  
positive 
PSMγ  
negative 
agr group 1 41 33 12 27 9 3 10 0 
agr group 2 10 6 0 0 4 0 6 2 
agrgroup 3 3 5 1 0 0 0 8 0 
agrgroup 4 2 0 0 0 0 0 0 0 
Total 
56 
(56%) 
44 
(44%) 
13   
(26%) 
27 
(68%) 
13 
(32%) 
3    
(19%) 
24 
(92%) 
2     
(8%) 
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Table 3. Biofilm formation results with correlation to agr specificity group and agr 
positive/negative phenotype based on the PSMγ results. 
 
No significant differences between agr specificity group and ability to form a biofilm in PJI, catheter or nasal 
isolates, p > 0.05. Statistics of PJI ability to form a biofilm vs. PSMγ positive/negative, p = 0.284; Catheter 
ability to form a biofilm vs. PSMγ positive/negative, p = 0.599; Control ability to form a biofilm vs. PSMγ 
positive/negative, p = 0.129 
 
  
  Strong 
biofilm  
(OD570 > 0.7) 
Positive 
biofilm 
(OD570 0.5-
0.69) 
Weak biofilm 
(OD570 0.2-
0.49) 
Negative 
biofilm       
(OD570 <0.19) 
PJI agr group 1 13 6 46 9 
 agr group 2 2 4 7 3 
 agr group 3 0 0 7 1 
 agr group 4 0 0 2 0 
 PSMγ positive 11 7 32 6 
 PSMγ negative 4 3 30 7 
Catheter agr group 1 9 5 22 0 
 agr group 2 0 0 4 0 
 agr group 3 0 0 0 0 
 agr group 4 0 0 0 0 
 PSMγ positive 5 5 17 0 
 PSMγ negative 4 0 9 0 
Control agr group 1 0 1 3 6 
 agr group 2 0 0 4 4 
 agr group 3 0 0 2 6 
 agr group 4 0 0 0 0 
 PSMγ positive 0 1 7 16 
 PSMγ negative 0 0 2 0 
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Supplemental Table 1. Primers used in this study, and the PCR/qRT-PCR conditions used 
 
 
 
 
 
  
Gene Primers PCR/qRT-PCR conditions Reference 
agr-specificity 
group 1 
Forward 5’-GAAACAACCTATACCTA-3’ 
Reverse 5’-GCAGAAGGGATTACAATCGT-3’ 
2 min, 94°C; 30 cycles of 15s,  94°C; 30s, 50°C; 1min, 
72°C; final extension 72°C for 7min 
This study 
agr-specificity 
group 2, 3 and 4 
Forward 5’-GAAACAACCTATACCTA-3’ 
Reverse 5’-GCAGAAAGGATTATAATTCCA-3’ 
2 min, 94°C; 30 cycles of 15s,   94°C; 30s, 50°C; 1min, 
72°C; final extension 72°C for 7min 
This study 
hld 
 
Forward 5’-GTTATGATGGCAGCAGA-3’ 
Reverse 5’-GGATGGCTCAACAACTCA-3’ 
3min, 95°C; 35 cycles of 30s, 94°C; 30s, 55°C; 30s, 72°C This study 
gyrB 
 
Forward 5’-CTGACAATGGCCGTGGTATTC-3’ 
Reverse 5’-GAAGATCCAACACCGTGAAGAC-3’ 
3min, 95°C; 35 cycles of 30s, 94°C; 30s, 55°C; 30s, 72°C 10 
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Supplemental Table 2. Detailed analysis of the HPLC and qRT-PCR results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No significant difference in RNAIII transcription or PSMγ between Prosthetic episodes / Catheter episodes & Control, p > 0.05
Prosthetic joint (n = 44 isolates; n = 22 episodes) 
  Distribution per isolate Variation  
between episodes 
Distribution per isolate Variation  
between episodes   RNAIII positive RNAIII negative PSMγ positive PSMγ negative 
agr group 1 27 5 5 23 9 7 
agr group 2 4 2 2 4 2 2 
agr group 3 4 0 0 3 1 0 
agr group 4 2 0 0 2 0 0 
Total 37 (84%) 7 (16%) 7 (16%) 32 (73%) 12 (27%) 9 (20%) 
       
Catheter (n = 22 isolates; n = 8 episodes) 
  Distribution per isolate Variation 
between episodes 
Distribution per isolate Variation 
between episodes   RNAIII positive RNAIII negative PSMγ positive PSMγ negative 
agr group 1 17 1 1 15 3 3 
agr group 2 4 0 0 0 4 0 
agr group 3 0 0 0 0 0 0 
agr group 4 0 0 0 0 0 0 
Total 21 (95%) 1 (5%) 1 (5%) 15 (68%) 7 (32%) 3 (38%) 
       
Nasal swabs (n = 9) 
  Distribution per isolate Variation 
between episodes 
Distribution per isolate Variation 
between episodes   RNAIII positive RNAIII negative PSMγ positive PSMγ negative 
agr group 1 3 0 n/a 3 0 n/a 
agr group 2 2 1 n/a 2 1 n/a 
agr group 3 2 1 n/a 3 0 n/a 
agr group 4 0 0 n/a 0 0 n/a  
Total 7 (78%) 2 (22%) n/a 8 (89%) 1 (11%) n/a 
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